Two hundred twenty-two subjects with symptomatic GSV incompetence were randomly assigned to receive either CAE ( n = 108 ) with the VenaSeal Sapheon Closure System ( Sapheon , Inc , Morrisville , NC ) or RFA ( n = 114 ) with the ClosureFast system ( Covidien , Mansfield , Mass ) .